169 related articles for article (PubMed ID: 33905035)
1. Do pentraxin 3 and neural pentraxin 2 have different facet function in hepatocellular carcinoma?
Cabiati M; Gaggini M; De Simone P; Del Ry S
Clin Exp Med; 2021 Nov; 21(4):555-562. PubMed ID: 33905035
[TBL] [Abstract][Full Text] [Related]
2. Pentraxin-3 is not related to disease severity in cirrhosis and hepatocellular carcinoma patients.
Feder S; Haberl EM; Spirk M; Weiss TS; Wiest R; Buechler C
Clin Exp Med; 2020 May; 20(2):289-297. PubMed ID: 32078718
[TBL] [Abstract][Full Text] [Related]
3. Genetic variation in PTX3 and plasma levels associated with hepatocellular carcinoma in patients with HCV.
Carmo RF; Aroucha D; Vasconcelos LR; Pereira LM; Moura P; Cavalcanti MS
J Viral Hepat; 2016 Feb; 23(2):116-22. PubMed ID: 26400151
[TBL] [Abstract][Full Text] [Related]
4. Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection.
Deng H; Fan X; Wang X; Zeng L; Zhang K; Zhang X; Li N; Han Q; Lv Y; Liu Z
Sci Rep; 2020 Nov; 10(1):20276. PubMed ID: 33219288
[TBL] [Abstract][Full Text] [Related]
5. Inducible expression of the long pentraxin PTX3 in the central nervous system.
Polentarutti N; Bottazzi B; Di Santo E; Blasi E; Agnello D; Ghezzi P; Introna M; Bartfai T; Richards G; Mantovani A
J Neuroimmunol; 2000 Jul; 106(1-2):87-94. PubMed ID: 10814786
[TBL] [Abstract][Full Text] [Related]
6. Long pentraxin PTX3 is upregulated systemically and centrally after experimental neurotrauma, but its depletion leaves unaltered sensorimotor deficits or histopathology.
Oggioni M; Mercurio D; Minuta D; Fumagalli S; Popiolek-Barczyk K; Sironi M; Ciechanowska A; Ippati S; De Blasio D; Perego C; Mika J; Garlanda C; De Simoni MG
Sci Rep; 2021 May; 11(1):9616. PubMed ID: 33953334
[TBL] [Abstract][Full Text] [Related]
7. Circulating levels of pentraxin-3 (PTX3) in patients with liver cirrhosis.
Narciso-Schiavon JL; Pereira JG; Silva TE; Bansho ETO; Morato EF; Pinheiro JT; Muraro-Wildner L; Bazzo ML; Dantas-Corrêa EB; Schiavon LL
Ann Hepatol; 2017; 16(5):780-787. PubMed ID: 28809733
[TBL] [Abstract][Full Text] [Related]
8. [The role of long pentraxin 3, a new inflammatory mediator in inflammatory responses].
Okutani D
Nihon Rinsho Meneki Gakkai Kaishi; 2006 Jun; 29(3):107-13. PubMed ID: 16819259
[TBL] [Abstract][Full Text] [Related]
9. Pentraxin 3 overexpression accelerated tumor metastasis and indicated poor prognosis in hepatocellular carcinoma via driving epithelial-mesenchymal transition.
Song T; Wang C; Guo C; Liu Q; Zheng X
J Cancer; 2018; 9(15):2650-2658. PubMed ID: 30087705
[TBL] [Abstract][Full Text] [Related]
10. The pentraxin family in autoimmune disease.
Li Y; Zhang S; Liu J; Zhang Y; Zhang N; Cheng Q; Zhang H; Wu X
Clin Chim Acta; 2023 Nov; 551():117592. PubMed ID: 37832905
[TBL] [Abstract][Full Text] [Related]
11. Clinical impact of pentraxin family expression on prognosis of pancreatic carcinoma.
Kondo S; Ueno H; Hosoi H; Hashimoto J; Morizane C; Koizumi F; Tamura K; Okusaka T
Br J Cancer; 2013 Aug; 109(3):739-46. PubMed ID: 23828517
[TBL] [Abstract][Full Text] [Related]
12. Elevated levels of the long pentraxin 3 in paracetamol-induced human acute liver injury.
Craig DG; Lee P; Pryde EA; Walker SW; Beckett GJ; Hayes PC; Simpson KJ
Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):359-67. PubMed ID: 23169308
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction.
Latini R; Maggioni AP; Peri G; Gonzini L; Lucci D; Mocarelli P; Vago L; Pasqualini F; Signorini S; Soldateschi D; Tarli L; Schweiger C; Fresco C; Cecere R; Tognoni G; Mantovani A;
Circulation; 2004 Oct; 110(16):2349-54. PubMed ID: 15477419
[TBL] [Abstract][Full Text] [Related]
14. Neuronal pentraxin II (NPTX2) is frequently down-regulated by promoter hypermethylation in pancreatic cancers.
Zhang L; Gao J; Li Z; Gong Y
Dig Dis Sci; 2012 Oct; 57(10):2608-14. PubMed ID: 22806544
[TBL] [Abstract][Full Text] [Related]
15. Expression of long pentraxin 3 in human nasal mucosa fibroblasts, tissues, and secretions of chronic rhinosinusitis without nasal polyps.
Tsai YJ; Hao CY; Chen CL; Wu PH; Wu WB
J Mol Med (Berl); 2020 May; 98(5):673-689. PubMed ID: 32239253
[TBL] [Abstract][Full Text] [Related]
16. Pentraxin 3 regulates tyrosine kinase inhibitor-associated cardiomyocyte contraction and mitochondrial dysfunction via ERK/JNK signalling pathways.
Chen YT; Masbuchin AN; Fang YH; Hsu LW; Wu SN; Yen CJ; Liu YW; Hsiao YW; Wang JM; Rohman MS; Liu PY
Biomed Pharmacother; 2023 Jan; 157():113962. PubMed ID: 36370523
[TBL] [Abstract][Full Text] [Related]
17. Long pentraxin 3 as a marker of COVID-19 severity: evidences and perspectives.
Assandri R; Accordino S; Canetta C; Buscarini E; Scartabellati A; Tolassi C; Serana F
Biochem Med (Zagreb); 2022 Jun; 32(2):020901. PubMed ID: 35464745
[TBL] [Abstract][Full Text] [Related]
18. Pentraxin-3 as a local inflammatory marker in chronic spontaneous urticaria.
Kasperska-Zajac A; Grzanka A; Misiolek M; Mazur B; Machura E
Cytokine; 2015 Dec; 76(2):566-568. PubMed ID: 25982553
[TBL] [Abstract][Full Text] [Related]
19. Increased Serum Pentraxin 3 Levels are Associated with Poor Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma.
Han Q; Deng H; Fan X; Wang X; Zhang X; Zhang K; Li N; Lv Y; Liu Z
J Hepatocell Carcinoma; 2021; 8():1367-1373. PubMed ID: 34805015
[TBL] [Abstract][Full Text] [Related]
20. The yin-yang of long pentraxin PTX3 in inflammation and immunity.
Daigo K; Mantovani A; Bottazzi B
Immunol Lett; 2014 Sep; 161(1):38-43. PubMed ID: 24792672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
